Skip to content
10-K

Annual Report

KALA BIO, Inc. KALA

0001104659-26-043782

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 10, 2026 929.49M sh
Shares Diluted FY 2025 · Dec 31, 2025 8.15M sh
Shares Diluted FY 2025 · Dec 31, 2024 3.8M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$31.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$29.38M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.56M
Cash And Equivalents FY 2025 · Dec 31, 2024 $51.18M
Stockholders Equity FY 2025 · Dec 31, 2025 $7M
Stockholders Equity FY 2025 · Dec 31, 2024 $12.33M
Stockholders Equity FY 2025 · Dec 31, 2023 $7.5M
Current Liabilities FY 2025 · Dec 31, 2025 $2.49M
Current Liabilities FY 2025 · Dec 31, 2024 $16.96M
Total Liabilities FY 2025 · Dec 31, 2025 $2.49M
Total Liabilities FY 2025 · Dec 31, 2024 $43.15M
Current Assets FY 2025 · Dec 31, 2025 $9.49M
Current Assets FY 2025 · Dec 31, 2024 $52.8M
Total Assets FY 2025 · Dec 31, 2025 $9.49M
Total Assets FY 2025 · Dec 31, 2024 $55.48M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.31
Eps Diluted FY 2025 · Dec 31, 2024 −$10.15
Eps Basic FY 2025 · Dec 31, 2025 −$3.31
Eps Basic FY 2025 · Dec 31, 2024 −$10.15
Net Income FY 2025 · Dec 31, 2025 −$26.98M
Net Income FY 2025 · Dec 31, 2024 −$38.51M
Operating Income FY 2025 · Dec 31, 2025 −$39.16M
Operating Income FY 2025 · Dec 31, 2024 −$40.98M
Long Term Debt FY 2025 · Dec 31, 2024 $20.1M
Short Term Debt FY 2025 · Dec 31, 2024 $10.34M